These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37551971)

  • 41. Competence remodels the pneumococcal cell wall exposing key surface virulence factors that mediate increased host adherence.
    Minhas V; Domenech A; Synefiaridou D; Straume D; Brendel M; Cebrero G; Liu X; Costa C; Baldry M; Sirard JC; Perez C; Gisch N; Hammerschmidt S; Håvarstein LS; Veening JW
    PLoS Biol; 2023 Jan; 21(1):e3001990. PubMed ID: 36716340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of binding of human lactoferrin to pneumococcal surface protein A.
    Håkansson A; Roche H; Mirza S; McDaniel LS; Brooks-Walter A; Briles DE
    Infect Immun; 2001 May; 69(5):3372-81. PubMed ID: 11292760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection.
    Katsura H; Piao Z; Iwatsuki-Horimoto K; Akeda Y; Watanabe S; Horimoto T; Oishi K; Kawaoka Y
    J Virol; 2014 Nov; 88(22):13410-7. PubMed ID: 25210171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular analyses identifies new domains and structural differences among Streptococcus pneumoniae immune evasion proteins PspC and Hic.
    Du S; Vilhena C; King S; Sahagún-Ruiz A; Hammerschmidt S; Skerka C; Zipfel PF
    Sci Rep; 2021 Jan; 11(1):1701. PubMed ID: 33462258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pneumococcal Surface Protein A Plays a Major Role in Streptococcus pneumoniae-Induced Immunosuppression.
    Saumyaa ; Pujanauski L; Colino J; Flora M; Torres RM; Tuomanen E; Snapper CM
    J Immunol; 2016 May; 196(9):3677-85. PubMed ID: 27029587
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Yamaguchi M; Hirose Y; Takemura M; Ono M; Sumitomo T; Nakata M; Terao Y; Kawabata S
    Front Cell Infect Microbiol; 2019; 9():301. PubMed ID: 31482074
    [No Abstract]   [Full Text] [Related]  

  • 47. Pneumococcal Adhesins PavB and PspC Are Important for the Interplay with Human Thrombospondin-1.
    Binsker U; Kohler TP; Krauel K; Kohler S; Schwertz H; Hammerschmidt S
    J Biol Chem; 2015 Jun; 290(23):14542-55. PubMed ID: 25897078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of human factor H with PspC of Streptococcus pneumoniae.
    Dave S; Pangburn MK; Pruitt C; McDaniel LS
    Indian J Med Res; 2004 May; 119 Suppl():66-73. PubMed ID: 15232165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterologous expression of pneumococcal virulence factor PspC on the surface of Lactococcus lactis confers adhesive properties.
    Asmat TM; Klingbeil K; Jensch I; Burchhardt G; Hammerschmidt S
    Microbiology (Reading); 2012 Mar; 158(Pt 3):771-780. PubMed ID: 22222496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.
    Ren B; Szalai AJ; Thomas O; Hollingshead SK; Briles DE
    Infect Immun; 2003 Jan; 71(1):75-85. PubMed ID: 12496151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The virulence of Streptococcus pneumoniae partially depends on dprA.
    Yu Y; Chang D; Xu H; Zhang X; Pan L; Xu C; Huang B; Zhou H; Li J; Guo J; Liu C
    Braz J Microbiol; 2017; 48(2):225-231. PubMed ID: 28011228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children.
    Browall S; Norman M; Tångrot J; Galanis I; Sjöström K; Dagerhamn J; Hellberg C; Pathak A; Spadafina T; Sandgren A; Bättig P; Franzén O; Andersson B; Örtqvist Å; Normark S; Henriques-Normark B
    J Infect Dis; 2014 Feb; 209(3):377-88. PubMed ID: 24009156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucosal Infections and Invasive Potential of Nonencapsulated
    Bradshaw JL; Pipkins HR; Keller LE; Pendarvis JK; McDaniel LS
    mBio; 2018 Jan; 9(1):. PubMed ID: 29339428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of choline-binding proteins to cell surface properties of Streptococcus pneumoniae.
    Swiatlo E; Champlin FR; Holman SC; Wilson WW; Watt JM
    Infect Immun; 2002 Jan; 70(1):412-5. PubMed ID: 11748210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA.
    Carvalho Mda G; Tondella ML; McCaustland K; Weidlich L; McGee L; Mayer LW; Steigerwalt A; Whaley M; Facklam RR; Fields B; Carlone G; Ades EW; Dagan R; Sampson JS
    J Clin Microbiol; 2007 Aug; 45(8):2460-6. PubMed ID: 17537936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
    Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
    Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The puzzle of zmpB and extensive chain formation, autolysis defect and non-translocation of choline-binding proteins in Streptococcus pneumoniae.
    Bergé M; García P; Iannelli F; Prère MF; Granadel C; Polissi A; Claverys JP
    Mol Microbiol; 2001 Mar; 39(6):1651-60. PubMed ID: 11260480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drastic reduction in the virulence of Streptococcus pneumoniae expressing type 2 capsular polysaccharide but lacking choline residues in the cell wall.
    Kharat AS; Tomasz A
    Mol Microbiol; 2006 Apr; 60(1):93-107. PubMed ID: 16556223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].
    Shaper M; Hollingshead SK; Benjamin WH; Briles DE
    Infect Immun; 2004 Sep; 72(9):5031-40. PubMed ID: 15321996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.